arXiv:2604. 23954v2 Announce Type: replace Abstract: Artificial Intelligence (AI) and Machine Learning (ML) models used in clinical settings are increasingly deployed to support clinical decision-making.
arXiv:2507.14077v2 Announce Type: replace-cross Abstract: Artificial intelligence (AI) algorithms are a critical part of state-of-the-art digital health technology for diabetes management. Yet, acces...
FairGlucose is a 300‑patient CGM cohort balanced across 12 demographic strata, providing 132,480 forecasting samples and 3,945 behavioral events. Benchmarking 33 models on 2‑hour glucose forecasting revealed that population‑level validation masks significant subgroup disparities, with error ratios ranging from 0.8 to 1.4 and T1D patients experiencing 6 mg/dL higher error than T2D. The study shows that these gaps persist across all models, align with clinically hard cases, and vary with input‑length sensitivity, underscoring the need for subgroup‑disaggregated reporting in digital health AI.
arXiv:2606. 16056v1 Announce Type: new Abstract: Dysglycemia, encompassing both prediabetes and diabetes, affects huge numbers of adults worldwide, yet many of them remain undiagnosed.
arXiv:2606. 12699v1 Announce Type: cross Abstract: Type 2 Diabetes (T2D) poses an increasing global health threat, demanding effective glycemic assessment to support personalized and improved diabetes care.
arXiv:2607. 15394v1 Announce Type: new Abstract: Black-box models limit the adoption of artificial intelligence in medicine due to their lack of interpretability and reproducibility.
arXiv:2607. 16253v1 Announce Type: cross Abstract: Machine learning-based Type 2 diabetes risk prediction models obtain good internal validation results but lose effectiveness in real-world applications due to deficient external testing and fairness assessment.
arXiv:2606. 06881v1 Announce Type: new Abstract: Blood glucose forecasting models are foundational for modern diabetes management systems, as reliable short-term predictions can enable proactive interventions, support automated insulin delivery, and reduce the risk of hypo- and hyperglycemic events.
arXiv:2607. 19006v1 Announce Type: new Abstract: Accurate forecasting of blood glucose concentration is key in the management of Type 1 Diabetes, facilitating early detection of adverse glycemic events and supporting timely therapeutic interventions.
arXiv:2608. 15309v1 Announce Type: new Abstract: Continuous multimodal sensing now allows human physiology to be observed throughout daily life rather than only during occasional clinical visits.
The paper introduces a statistically grounded framework for interpretable, rule-based clinical classification using Bernoulli Naïve Bayes (BNB). It employs supervised chi‑square‑guided binarization to convert continuous medical variables into binary indicators, enabling BNB to handle continuous data while maintaining transparency. On three benchmark datasets—Pima Indians Diabetes, Wisconsin Breast Cancer, and Heart Failure Prediction—the method achieved AUCs of 0.800, 0.984, and 0.919, respectively, and demonstrated reliable probability calibration through cross‑validated analysis and post‑hoc beta calibration.
The paper introduces a new method for timely risk classification in clinical monitoring, framing the problem as a multi‑objective optimization that balances early classification, sensitivity, specificity, and monitoring cost. It derives an optimal decision rule via a value recursion and estimates it from data using a recurrent neural network combined with a primal–dual updating scheme to enforce performance constraints. Experiments, including a case study on continuous glucose monitoring for hypoglycemia prediction, show that the approach produces accurate, timely decision rules that meet the specified operating characteristics.
arXiv:2608.31128v1 Announce Type: new Abstract: Large language models (LLMs) offer promising clinical decision support but remain vulnerable to hallucinated facts, unsupported recommendations, and ci...